Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jedd D Wolchok

Showing results (1-10 of 450) with videos related to

Pageof 45
Sort By:
Nature Reviews. Immunology|February 6, 2018
Altered self: the not-so-neo-antigensJedd D Wolchok
Cell|August 29, 2015
PD-1 BlockersJedd D Wolchok
Scientific American|May 3, 2014
Cancer's off switchJedd D Wolchok
Nature Reviews. Immunology|September 28, 2021
Checkpoint blockade: the end of the beginningJedd D Wolchok
Clinical Advances in Hematology & Oncology : H&O|December 29, 2012
Emerging therapies in melanomaJedd D Wolchok
Journal of Translational Medicine|April 20, 2004
Tumor antigens for cancer immunotherapy: therapeutic potential of xenogeneic DNA vaccinesRoopa Srinivasan, Jedd D Wolchok
Current Opinion in Immunology|April 9, 2013
Combining cancer immunotherapy and targeted therapyAntoni Ribas, Jedd D Wolchok
Cell|June 3, 2017
Curbing Tregs' (Lack of) EnthusiasmTaha Merghoub, Jedd D Wolchok
The Oncologist|November 15, 2008
The mechanism of anti-CTLA-4 activity and the negative regulation of T-cell activationJedd D Wolchok, Yvonne Saenger
The Journal of Experimental Medicine|November 19, 2014
Immunotherapy and the belly of the beastTaha Merghoub, Jedd D Wolchok
Pageof 45

Showing results (1-10 of 450) with videos related to

Sort By:
Pageof 45
Nature Reviews. Immunology|February 6, 2018
Altered self: the not-so-neo-antigensJedd D Wolchok
Cell|August 29, 2015
PD-1 BlockersJedd D Wolchok
Scientific American|May 3, 2014
Cancer's off switchJedd D Wolchok
Nature Reviews. Immunology|September 28, 2021
Checkpoint blockade: the end of the beginningJedd D Wolchok
Clinical Advances in Hematology & Oncology : H&O|December 29, 2012
Emerging therapies in melanomaJedd D Wolchok
Journal of Translational Medicine|April 20, 2004
Tumor antigens for cancer immunotherapy: therapeutic potential of xenogeneic DNA vaccinesRoopa Srinivasan, Jedd D Wolchok
Current Opinion in Immunology|April 9, 2013
Combining cancer immunotherapy and targeted therapyAntoni Ribas, Jedd D Wolchok
Cell|June 3, 2017
Curbing Tregs' (Lack of) EnthusiasmTaha Merghoub, Jedd D Wolchok
The Oncologist|November 15, 2008
The mechanism of anti-CTLA-4 activity and the negative regulation of T-cell activationJedd D Wolchok, Yvonne Saenger
The Journal of Experimental Medicine|November 19, 2014
Immunotherapy and the belly of the beastTaha Merghoub, Jedd D Wolchok
Pageof 45